ASCO 2026 - with Dr. Katarzyna Jerzak: HER2CLIMB-05 Update

Dr. Katarzyna Jerzak reviews ASCO 2026 updates from HER2CLIMB-05, highlighting tucatinib maintenance in HER2-positive metastatic breast cancer and its implications for upcoming REAL Alliance Canadian consensus recommendations.